Daljit Tatla

527 total citations
10 papers, 343 citations indexed

About

Daljit Tatla is a scholar working on Cardiology and Cardiovascular Medicine, Rheumatology and Neurology. According to data from OpenAlex, Daljit Tatla has authored 10 papers receiving a total of 343 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Cardiology and Cardiovascular Medicine, 4 papers in Rheumatology and 3 papers in Neurology. Recurrent topics in Daljit Tatla's work include Rheumatoid Arthritis Research and Therapies (4 papers), Cardiac pacing and defibrillation studies (3 papers) and Cardiac electrophysiology and arrhythmias (3 papers). Daljit Tatla is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (4 papers), Cardiac pacing and defibrillation studies (3 papers) and Cardiac electrophysiology and arrhythmias (3 papers). Daljit Tatla collaborates with scholars based in United States, Germany and United Kingdom. Daljit Tatla's co-authors include Paul Dorian, Stefan H. Hohnloser, José M. Brum, Hussein R. Al‐Khalidi, Patrick Tchou, Craig M. Pratt, Martin Borggrefe, Igor Singer, Robert J. Myerburg and David S. Cannom and has published in prestigious journals such as Circulation, European Heart Journal and The American Journal of Cardiology.

In The Last Decade

Daljit Tatla

10 papers receiving 334 citations

Peers

Daljit Tatla

CCM

RHEUM

NEURO

HEMAT

IMMUN

Helena Borrell Spain

Aleid C. Boer Netherlands

Edouard Haller Switzerland

Klearchos Psychogios Greece

Carlos Clayton Macedo de Freitas Brazil

Jonathan Scoville United States

Tom Dewaele Belgium

M H Gottesman United States

Solveig Wållberg Jonsson Sweden

Miguel A. Barboza Mexico

Helena Borrell Spain

Daljit Tatla

24 ×0.1

CCM

51 ×0.7

RHEUM

37 ×1.2

NEURO

30 ×0.9

HEMAT

19 ×0.8

IMMUN

Citations per year, relative to Daljit Tatla Daljit Tatla (= 1×) peers Helena Borrell

Countries citing papers authored by Daljit Tatla

Since Specialization

Citations

This map shows the geographic impact of Daljit Tatla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daljit Tatla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daljit Tatla more than expected).

Fields of papers citing papers by Daljit Tatla

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daljit Tatla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daljit Tatla. The network helps show where Daljit Tatla may publish in the future.

Co-authorship network of co-authors of Daljit Tatla

This figure shows the co-authorship network connecting the top 25 collaborators of Daljit Tatla. A scholar is included among the top collaborators of Daljit Tatla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daljit Tatla. Daljit Tatla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Kivitz, Alan, et al.. (2023). Safe and Effective Subcutaneous Self-Injection of Bimekizumab with Safety Syringe and Auto-Injector Devices: Results from a Multicenter, Randomized, Open-Label Study in Patients with Psoriatic Arthritis. Patient Preference and Adherence. Volume 17. 2451–2461. 2 indexed citations

Bagel, Jerry, et al.. (2022). Bimekizumab Self-Injection Devices: Two Multicenter, Randomized, Open-Label Studies on Self-Administration by Patients With Psoriasis. Journal of Drugs in Dermatology. 21(2). 162–171. 3 indexed citations

Tatla, Daljit, et al.. (2020). A multicenter, open-label study to evaluate the safe and effective use of a new electromechanical auto-injection device for self-injection of certolizumab pegol. Expert Opinion on Drug Delivery. 17(6). 855–862. 6 indexed citations

Boroojerdi, Babak, Roozbeh Ghaffari, Nikhil Mahadevan, et al.. (2018). Clinical feasibility of a wearable, conformable sensor patch to monitor motor symptoms in Parkinson's disease. Parkinsonism & Related Disorders. 61. 70–76. 30 indexed citations

Emery, Paul, Clifton O. Bingham, Gerd R Burmester, et al.. (2016). Certolizumab pegol in combination with dose-optimised methotrexate in DMARD-naïve patients with early, active rheumatoid arthritis with poor prognostic factors: 1-year results from C-EARLY, a randomised, double-blind, placebo-controlled phase III study. Annals of the Rheumatic Diseases. 76(1). 96–104. 72 indexed citations

Emery, Paul, Clifton O. Bingham, Gerd R Burmester, et al.. (2015). SAT0164 The First Study of Certolizumab Pegol in Combination with Methotrexate in Dmard-Naïve Early Rheumatoid Arthritis Patients Led to Sustained Clinical Response and Inhibition of Radiographic Progression at 52 Weeks: The C-Early Randomized, Double-Blind, Controlled Phase 3 Study. Annals of the Rheumatic Diseases. 74. 712–712. 4 indexed citations

Schwiers, Michael, et al.. (2012). A Randomized Study Comparing Outcomes of Stapled and Hand-Sutured Anastomoses in Patients Undergoing Open Gastrointestinal Surgery. Indian Journal of Surgery. 75(4). 311–316. 5 indexed citations

Hohnloser, Stefan H., Hussein R. Al‐Khalidi, José M. Brum, et al.. (2006). Electrical storm in patients with an implantable defibrillator: incidence, features, and preventive therapy: insights from a randomized trial. European Heart Journal. 27(24). 3027–3032. 119 indexed citations

Pratt, Craig M., Paul Dorian, Hussein R. Al‐Khalidi, et al.. (2005). Design of the SHock Inhibition Evaluation with Azimilide (SHIELD) study: A novel method to assess antiarrhythmic drug effect in patients with an implantable cardioverter-defibrillator. The American Journal of Cardiology. 95(2). 274–276. 1 indexed citations

10.

Dorian, Paul, Martin Borggrefe, Hussein R. Al‐Khalidi, et al.. (2004). Placebo-Controlled, Randomized Clinical Trial of Azimilide for Prevention of Ventricular Tachyarrhythmias in Patients With an Implantable Cardioverter Defibrillator. Circulation. 110(24). 3646–3654. 101 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact